Jaiprakash Associates Ltd. - Research Center
532532 JPASSOCIAT Group (T) BSE data
Add to watchlist
| Results |
Quarterly
|
| Statement | |
| More |
Quarterly results in brief
(Rs crore)
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Sales | 935.42 | 710.09 | 1,213.61 | 688.86 | 1,190.86 |
| Operating profit | 142.10 | 57.13 | 49.88 | 44.32 | 222.96 |
| Interest | 246.64 | 243.16 | 228.91 | 194.19 | 143.40 |
| Gross profit | -70.71 | -134.31 | -133.81 | -75.23 | 126.33 |
| EPS (Rs) | -2.75 | -1.97 | -0.85 | -0.70 | -1.12 |
Quarterly
results in details
| Mar' 24 | Dec' 23 | Sep' 23 | Jun' 23 | Mar' 23 | |
|---|---|---|---|---|---|
| Other income | 33.83 | 51.72 | 45.22 | 74.64 | 46.77 |
| Stock adjustment | 6.89 | 3.57 | 0.76 | 0.42 | -10.00 |
| Raw material | 225.34 | 184.49 | 190.03 | 171.58 | 288.69 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 89.85 | 77.60 | 77.63 | 81.06 | 86.96 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 471.24 | 387.30 | 895.31 | 391.48 | 602.25 |
| Provisions made | - | - | - | - | - |
| Depreciation | 58.16 | 58.77 | 60.30 | 59.33 | 58.08 |
| Taxation | 5.06 | 9.62 | 1.79 | 3.86 | 1.78 |
| Net profit / loss | -674.42 | -482.41 | -207.55 | -171.88 | -275.48 |
| Extra ordinary item | -540.49 | -279.71 | -11.65 | -33.46 | -341.95 |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 490.92 | 490.92 | 490.92 | 490.92 | 490.92 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 15.19 | 8.05 | 4.11 | 6.43 | 18.72 |
| GPM (%) | -7.30 | -17.63 | -10.63 | -9.85 | 10.21 |
| NPM (%) | -69.58 | -63.32 | -16.49 | -22.51 | -22.26 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis